We used a comprehensive SNP tagging approach using the publicly available HapMap data, complemented by the random selection of SNPs from dbSNP, to determine if common variation in the ERBB2 amplicon is involved in breast cancer susceptibility. This evidence concerns the gene ERBB2 and breast carcinoma.